Cargando…
Inflammatory IFIT3 renders chemotherapy resistance by regulating post-translational modification of VDAC2 in pancreatic cancer
Pancreatic ductal adenocarcinoma (PDAC) is one of the most lethal cancers worldwide and effective therapy remains a challenge. IFIT3 is an interferon-stimulated gene with antiviral and pro-inflammatory functions. Our previous work has shown that high expression of IFIT3 is correlated with poor survi...
Autores principales: | Wang, Zhefang, Qin, Jie, Zhao, Jiangang, Li, Jiahui, Li, Dai, Popp, Marie, Popp, Felix, Alakus, Hakan, Kong, Bo, Dong, Qiongzhu, Nelson, Peter J., Zhao, Yue, Bruns, Christiane J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7330856/ https://www.ncbi.nlm.nih.gov/pubmed/32641986 http://dx.doi.org/10.7150/thno.43093 |
Ejemplares similares
-
Targeting Cancer Stem Cells and Their Niche: Current Therapeutic Implications and Challenges in Pancreatic Cancer
por: Zhao, Jiangang, et al.
Publicado: (2017) -
Tumor-Derived Extracellular Vesicles Inhibit Natural Killer Cell Function in Pancreatic Cancer
por: Zhao, Jiangang, et al.
Publicado: (2019) -
Protocol of the PANCALYZE trial: a multicenter, prospective study investigating the tumor biomarkers CXCR4, SMAD4, SOX9 and IFIT3 in patients with resected pancreatic adenocarcinoma to predict the pattern of recurrence of the disease
por: Popp, Felix C., et al.
Publicado: (2017) -
IFIT3 and IFIT2/3 promote IFIT1-mediated translation inhibition by enhancing binding to non-self RNA
por: Fleith, Renata C, et al.
Publicado: (2018) -
Targeting Glutaminolysis: New Perspectives to Understand Cancer Development and Novel Strategies for Potential Target Therapies
por: Wang, Zhefang, et al.
Publicado: (2020)